Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionpoly(A) binding

HNRNPDL SYNCRIP

5.67e-052982GO:0008143
GeneOntologyMolecularFunctionpoly-purine tract binding

HNRNPDL SYNCRIP

9.29e-053782GO:0070717
GeneOntologyMolecularFunctionsingle-stranded RNA binding

HNRNPDL SYNCRIP

8.39e-0411182GO:0003727
GeneOntologyMolecularFunctionmRNA binding

RBM5 SYNCRIP HNRNPR

2.05e-0369483GO:0003729
GeneOntologyMolecularFunctionmRNA 3'-UTR binding

SYNCRIP HNRNPR

5.05e-0327682GO:0003730
GeneOntologyBiologicalProcessmRNA metabolic process

HNRNPDL RBM5 SYNCRIP HNRNPR

2.35e-0491784GO:0016071
GeneOntologyBiologicalProcessmRNA splicing, via spliceosome

RBM5 SYNCRIP HNRNPR

2.72e-0435883GO:0000398
GeneOntologyBiologicalProcessRNA splicing, via transesterification reactions with bulged adenosine as nucleophile

RBM5 SYNCRIP HNRNPR

2.72e-0435883GO:0000377
GeneOntologyBiologicalProcessRNA splicing, via transesterification reactions

RBM5 SYNCRIP HNRNPR

2.81e-0436283GO:0000375
GeneOntologyBiologicalProcessregulation of mRNA metabolic process

RBM5 SYNCRIP HNRNPR

5.09e-0444383GO:1903311
GeneOntologyBiologicalProcessRNA splicing

RBM5 SYNCRIP HNRNPR

7.33e-0450283GO:0008380
GeneOntologyBiologicalProcessmRNA processing

RBM5 SYNCRIP HNRNPR

9.60e-0455183GO:0006397
GeneOntologyBiologicalProcessmRNA destabilization

SYNCRIP HNRNPR

2.67e-0320682GO:0061157
GeneOntologyBiologicalProcesspositive regulation of mRNA catabolic process

SYNCRIP HNRNPR

2.80e-0321182GO:0061014
GeneOntologyBiologicalProcessRNA destabilization

SYNCRIP HNRNPR

2.80e-0321182GO:0050779
GeneOntologyBiologicalProcesspositive regulation of mRNA metabolic process

SYNCRIP HNRNPR

4.18e-0325982GO:1903313
GeneOntologyBiologicalProcessregulation of mRNA stability

SYNCRIP HNRNPR

5.29e-0329282GO:0043488
GeneOntologyBiologicalProcessregulation of RNA stability

SYNCRIP HNRNPR

5.86e-0330882GO:0043487
GeneOntologyBiologicalProcessregulation of mRNA catabolic process

SYNCRIP HNRNPR

5.90e-0330982GO:0061013
GeneOntologyCellularComponentspliceosomal complex

RBM5 SYNCRIP HNRNPR

5.78e-0521583GO:0005681
GeneOntologyCellularComponentcatalytic step 2 spliceosome

SYNCRIP HNRNPR

5.86e-049782GO:0071013
GeneOntologyCellularComponentnuclear protein-containing complex

RBM5 SS18 SYNCRIP HNRNPR

1.06e-03137784GO:0140513
GeneOntologyCellularComponentchromatin

HNRNPDL SS18 ZC3H6 AKAP8

1.39e-03148084GO:0000785
GeneOntologyCellularComponentribonucleoprotein complex

RBM5 SYNCRIP HNRNPR

8.38e-03119483GO:1990904
DomainRRM_1

HNRNPDL RBM5 SYNCRIP HNRNPR

1.01e-0620884PF00076
DomainRRM

HNRNPDL RBM5 SYNCRIP HNRNPR

1.20e-0621784SM00360
DomainRRM_dom

HNRNPDL RBM5 SYNCRIP HNRNPR

1.43e-0622784IPR000504
DomainRRM

HNRNPDL RBM5 SYNCRIP HNRNPR

1.51e-0623084PS50102
DomainHnRNP_R/Q_splicing_fac

SYNCRIP HNRNPR

1.60e-06582IPR006535
Domain-

HNRNPDL RBM5 SYNCRIP HNRNPR

1.91e-06244843.30.70.330
DomainNucleotide-bd_a/b_plait

HNRNPDL RBM5 SYNCRIP HNRNPR

2.38e-0625884IPR012677
PathwayWP_MRNA_PROCESSING

HNRNPDL RBM5 SYNCRIP HNRNPR

3.35e-0545174MM15946
PathwayWP_MRNA_PROCESSING

RBM5 HNRNPR

1.62e-0312672M39406
PathwayREACTOME_MRNA_SPLICING

RBM5 HNRNPR

4.05e-0320172MM15411
PathwayREACTOME_MRNA_SPLICING

RBM5 HNRNPR

4.50e-0321272M14033
PathwayREACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA

RBM5 HNRNPR

7.57e-0327772MM15414
PathwayREACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA

RBM5 HNRNPR

7.89e-0328372M13087
Pubmed

Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.

HNRNPDL SS18 SYNCRIP HNRNPR AKAP8

1.38e-084218534650049
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

5.28e-085518534728620
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

8.40e-086058528977666
Pubmed

Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS.

SYNCRIP HNRNPR

1.39e-0738230755280
Pubmed

Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.

HNRNPDL SYNCRIP HNRNPR AKAP8

1.62e-072448429884807
Pubmed

SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.

HNRNPDL SYNCRIP HNRNPR AKAP8

2.02e-072588437794589
Pubmed

Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.

HNRNPDL SYNCRIP HNRNPR AKAP8

2.09e-072608436199071
Pubmed

mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.

RBM5 SYNCRIP HNRNPR AKAP8

2.57e-072748434244482
Pubmed

SMN interacts with a novel family of hnRNP and spliceosomal proteins.

SYNCRIP HNRNPR

2.78e-0748211574476
Pubmed

Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?

SYNCRIP HNRNPR

2.78e-0748211773003
Pubmed

The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

3.51e-078078522681889
Pubmed

PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.

HNRNPDL SYNCRIP HNRNPR AKAP8

6.09e-073408424332808
Pubmed

A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.

HNRNPDL RBM5 SYNCRIP HNRNPR

6.61e-073478416033648
Pubmed

DBIRD complex integrates alternative mRNA splicing with RNA polymerase II transcript elongation.

SYNCRIP HNRNPR AKAP8

8.99e-07898322446626
Pubmed

Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.

HNRNPDL SYNCRIP HNRNPR

9.30e-07908323151878
Pubmed

Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.

SYNCRIP HNRNPR AKAP8

9.30e-07908333087562
Pubmed

MYC multimers shield stalled replication forks from RNA polymerase.

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

9.60e-079898536424410
Pubmed

Identification of a heterogeneous nuclear ribonucleoprotein-recognition region in the HIV Rev protein.

SYNCRIP HNRNPR

1.30e-0688219808671
Pubmed

Identification of methylated proteins by protein arginine N-methyltransferase 1, PRMT1, with a new expression cloning strategy.

SYNCRIP HNRNPR

1.30e-0688212183049
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

RBM5 ZC3H6 SYNCRIP HNRNPR AKAP8

1.50e-0610828538697112
Pubmed

Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes.

RBM5 SYNCRIP HNRNPR

1.95e-061158317332742
Pubmed

Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma.

HNRNPDL SYNCRIP HNRNPR

1.95e-061158320000738
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

HNRNPDL SS18 SYNCRIP HNRNPR AKAP8

2.06e-0611558520360068
Pubmed

Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.

HNRNPDL SYNCRIP HNRNPR

2.27e-061218334029587
Pubmed

LINKIN, a new transmembrane protein necessary for cell adhesion.

HNRNPDL SYNCRIP HNRNPR AKAP8

2.40e-064808425437307
Pubmed

SYNCRIP, a cytoplasmic counterpart of heterogeneous nuclear ribonucleoprotein R, interacts with ubiquitous synaptotagmin isoforms.

SYNCRIP HNRNPR

2.54e-06118210734137
Pubmed

RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway.

SYNCRIP HNRNPR

2.54e-06118237142680
Pubmed

CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.

HNRNPDL SYNCRIP HNRNPR AKAP8

2.69e-064948426831064
Pubmed

Interactome Analysis Reveals a Novel Role for RAD6 in the Regulation of Proteasome Activity and Localization in Response to DNA Damage.

HNRNPDL SYNCRIP HNRNPR

2.88e-061318328031328
Pubmed

The activity of the spinal muscular atrophy protein is regulated during development and cellular differentiation.

SYNCRIP HNRNPR

3.05e-06128216236758
Pubmed

Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.

HNRNPDL SYNCRIP HNRNPR

3.23e-061368326979993
Pubmed

H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

3.61e-0612948530804502
Pubmed

The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.

HNRNPDL SYNCRIP HNRNPR

4.08e-061478328977470
Pubmed

A receptor for activated C kinase is part of messenger ribonucleoprotein complexes associated with polyA-mRNAs in neurons.

SYNCRIP HNRNPR

6.29e-06178212388589
Pubmed

Phosphorylation switches protein disulfide isomerase activity to maintain proteostasis and attenuate ER stress.

SYNCRIP HNRNPR AKAP8

6.77e-061748332149426
Pubmed

A protein interaction landscape of breast cancer.

HNRNPDL SS18 SYNCRIP HNRNPR

7.22e-066348434591612
Pubmed

PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation.

HNRNPDL SYNCRIP HNRNPR AKAP8

9.42e-066788430209976
Pubmed

Profiling of Parkin-binding partners using tandem affinity purification.

HNRNPDL SYNCRIP HNRNPR

1.07e-052038324244333
Pubmed

Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.

HNRNPDL SYNCRIP HNRNPR

1.12e-052068322174317
Pubmed

RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.

HNRNPDL SYNCRIP HNRNPR AKAP8

1.15e-057138429802200
Pubmed

Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.

HNRNPDL SYNCRIP HNRNPR AKAP8

1.15e-057148428302793
Pubmed

Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.

HNRNPDL SYNCRIP HNRNPR

1.42e-052238320020773
Pubmed

The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.

HNRNPDL SYNCRIP HNRNPR AKAP8

1.47e-057598435915203
Pubmed

BioID-based Identification of Skp Cullin F-box (SCF)β-TrCP1/2 E3 Ligase Substrates.

HNRNPDL SYNCRIP HNRNPR

1.48e-052268325900982
Pubmed

A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.

HNRNPDL RBM5 AKAP8

1.60e-052328325515538
Pubmed

Identification of proteins associated with ligand-activated estrogen receptor α in human breast cancer cell nuclei by tandem affinity purification and nano LC-MS/MS.

SYNCRIP HNRNPR AKAP8

1.88e-052458321182205
Pubmed

PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase.

HNRNPDL HNRNPR AKAP8

1.93e-052478332989298
Pubmed

A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis.

RBM5 SYNCRIP HNRNPR

2.10e-052548328431233
Pubmed

Interaction proteomics of the HMGA chromatin architectural factors.

HNRNPDL SYNCRIP

2.29e-05328218850631
Pubmed

Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.

HNRNPDL SYNCRIP HNRNPR

2.55e-052718332433965
Pubmed

Molecular composition of IMP1 ribonucleoprotein granules.

SYNCRIP HNRNPR

2.91e-05368217289661
Pubmed

TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.

HNRNPDL SYNCRIP HNRNPR AKAP8

3.15e-059228427609421
Pubmed

The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases.

HNRNPDL AKAP8

3.60e-05408234004371
Pubmed

The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.

HNRNPDL SS18 SYNCRIP HNRNPR

3.61e-059548436373674
Pubmed

In silico APC/C substrate discovery reveals cell cycle-dependent degradation of UHRF1 and other chromatin regulators.

HNRNPDL SYNCRIP HNRNPR AKAP8

3.86e-059718433306668
Pubmed

NudCL2 regulates cell migration by stabilizing both myosin-9 and LIS1 with Hsp90.

HNRNPDL SYNCRIP HNRNPR

4.70e-053338332665550
Pubmed

Identifying biological pathways that underlie primordial short stature using network analysis.

HNRNPDL SYNCRIP HNRNPR AKAP8

4.76e-0510248424711643
Pubmed

ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.

HNRNPDL SYNCRIP HNRNPR

4.83e-053368331253590
Pubmed

Identification of DeltaNp63alpha protein interactions by mass spectrometry.

SYNCRIP HNRNPR

5.19e-05488220085233
Pubmed

hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.

HNRNPDL HNRNPR AKAP8

5.27e-053468325324306
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

HNRNPDL RBM5 SYNCRIP HNRNPR

6.36e-0511038434189442
Pubmed

The RNA-binding ubiquitin ligase MKRN1 functions in ribosome-associated quality control of poly(A) translation.

SYNCRIP AKAP8

6.83e-05558231640799
Pubmed

Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.

RBM5 SYNCRIP HNRNPR

7.12e-053838329331416
Pubmed

Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.

HNRNPDL RBM5 SYNCRIP

7.18e-053848331059266
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

HNRNPDL SYNCRIP HNRNPR AKAP8

7.46e-0511498435446349
Pubmed

Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme.

HNRNPDL SYNCRIP HNRNPR

7.52e-053908317643375
Pubmed

Regulation of error-prone translesion synthesis by Spartan/C1orf124.

HNRNPDL SYNCRIP

7.87e-05598223254330
Pubmed

Conserved expression of ultra-conserved noncoding RNA in mammalian nervous system.

HNRNPDL SYNCRIP

8.14e-05608229055695
Pubmed

Exploring an Alternative Cysteine-Reactive Chemistry to Enable Proteome-Wide PPI Analysis by Cross-Linking Mass Spectrometry.

HNRNPDL SYNCRIP HNRNPR

8.78e-054118336652389
Pubmed

RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.

HNRNPDL SYNCRIP HNRNPR

9.69e-054258321081503
Pubmed

TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.

HNRNPDL SYNCRIP HNRNPR

1.00e-044308338172120
Pubmed

C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.

HNRNPDL SYNCRIP HNRNPR AKAP8

1.06e-0412578437317656
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

HNRNPDL SYNCRIP HNRNPR AKAP8

1.06e-0412578436526897
Pubmed

Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.

HNRNPDL SYNCRIP HNRNPR

1.08e-044418331239290
Pubmed

New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.

HNRNPDL SYNCRIP AKAP8

1.24e-044628331138677
Pubmed

High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.

HNRNPDL SYNCRIP HNRNPR

1.30e-044698337314180
Pubmed

Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.

HNRNPDL SYNCRIP HNRNPR AKAP8

1.34e-0413358429229926
Pubmed

Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents.

HNRNPDL SYNCRIP HNRNPR

1.44e-044868330940648
Pubmed

TRIM24 is an insulin-responsive regulator of P-bodies.

SYNCRIP HNRNPR

1.45e-04808235803934
Pubmed

Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis.

SYNCRIP HNRNPR

1.45e-04808211991638
Pubmed

Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.

HNRNPDL SYNCRIP HNRNPR

1.49e-044918322623428
Pubmed

A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets.

SS18 SYNCRIP HNRNPR

1.60e-045038336217030
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

HNRNPDL RBM5 SYNCRIP HNRNPR

1.72e-0414258430948266
Pubmed

Human transcription factor protein interaction networks.

SS18 SYNCRIP HNRNPR AKAP8

1.74e-0414298435140242
Pubmed

Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.

SYNCRIP HNRNPR

1.75e-04888226318153
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

HNRNPDL RBM5 SYNCRIP HNRNPR

1.80e-0414428435575683
Pubmed

Cullin-3/KCTD10 complex is essential for K27-polyubiquitination of EIF3D in human hepatocellular carcinoma HepG2 cells.

SYNCRIP HNRNPR

1.84e-04908231280863
Pubmed

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.

HNRNPDL SYNCRIP HNRNPR

2.17e-045588327591049
Pubmed

Proteomic dissection of the von Hippel-Lindau (VHL) interactome.

HNRNPDL HNRNPR

2.18e-04988221942715
InteractionRBM14 interactions

HNRNPDL RBM5 SS18 SYNCRIP HNRNPR AKAP8

1.11e-0855386int:RBM14
InteractionTRIM31 interactions

HNRNPDL SS18 SYNCRIP HNRNPR AKAP8

3.01e-0745485int:TRIM31
InteractionFBXW11 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

3.68e-0747385int:FBXW11
InteractionCELF1 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR

2.73e-0628884int:CELF1
InteractionDDX21 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

2.90e-0671885int:DDX21
InteractionCHD3 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

3.76e-0675785int:CHD3
InteractionFUS interactions

HNRNPDL SS18 SYNCRIP HNRNPR AKAP8

3.76e-0675785int:FUS
InteractionGLDC interactions

RBM5 SYNCRIP HNRNPR AKAP8

4.20e-0632184int:GLDC
InteractionBTRC interactions

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

4.22e-0677585int:BTRC
InteractionWDR77 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR

6.70e-0636184int:WDR77
InteractionMIRLET7D interactions

RBM5 SYNCRIP HNRNPR

6.72e-0610183int:MIRLET7D
InteractionRNF2 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

7.28e-0686685int:RNF2
InteractionMIRLET7E interactions

RBM5 SYNCRIP HNRNPR

7.77e-0610683int:MIRLET7E
InteractionMIRLET7I interactions

RBM5 SYNCRIP HNRNPR

9.67e-0611483int:MIRLET7I
InteractionPRMT1 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

1.03e-0592985int:PRMT1
InteractionMIRLET7G interactions

RBM5 SYNCRIP HNRNPR

1.05e-0511783int:MIRLET7G
InteractionCHD4 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

1.08e-0593885int:CHD4
InteractionHNRNPA1 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

1.12e-0594585int:HNRNPA1
InteractionDDX17 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR

1.29e-0542684int:DDX17
InteractionKHDRBS2 interactions

HNRNPDL SYNCRIP HNRNPR

1.40e-0512983int:KHDRBS2
InteractionSNRPC interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

1.46e-0544084int:SNRPC
InteractionUBE2S interactions

HNRNPDL SYNCRIP HNRNPR

1.72e-0513883int:UBE2S
InteractionIL7R interactions

HNRNPDL SYNCRIP HNRNPR

1.83e-0514183int:IL7R
InteractionDAZL interactions

HNRNPDL SYNCRIP HNRNPR

1.99e-0514583int:DAZL
InteractionSNRPA interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

2.10e-0548284int:SNRPA
InteractionCOPS5 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR AKAP8

2.36e-05110285int:COPS5
InteractionDHX15 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR

2.46e-0550284int:DHX15
InteractionSNRPB interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

2.76e-0551784int:SNRPB
InteractionCPSF6 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

2.95e-0552684int:CPSF6
InteractionITFG1 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

3.28e-0554084int:ITFG1
InteractionLSM4 interactions

RBM5 SYNCRIP HNRNPR

3.67e-0517883int:LSM4
InteractionDDX5 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

3.99e-0556884int:DDX5
InteractionFAM20C interactions

SYNCRIP HNRNPR AKAP8

4.32e-0518883int:FAM20C
InteractionMECP2 interactions

RBM5 ZC3H6 SYNCRIP HNRNPR AKAP8

5.02e-05128785int:MECP2
InteractionRBM45 interactions

HNRNPDL SYNCRIP HNRNPR

5.76e-0520783int:RBM45
InteractionNR4A1 interactions

SYNCRIP HNRNPR AKAP8

6.18e-0521283int:NR4A1
InteractionBRD7 interactions

HNRNPDL SS18 SYNCRIP HNRNPR

6.25e-0563784int:BRD7
InteractionCMTR1 interactions

RBM5 SYNCRIP HNRNPR

6.72e-0521883int:CMTR1
InteractionU2AF2 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR

6.81e-0565184int:U2AF2
InteractionMYCN interactions

HNRNPDL SS18 SYNCRIP HNRNPR AKAP8

6.86e-05137385int:MYCN
InteractionMATR3 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

6.97e-0565584int:MATR3
InteractionOASL interactions

SYNCRIP HNRNPR AKAP8

7.19e-0522383int:OASL
InteractionUBE2A interactions

HNRNPDL SYNCRIP HNRNPR

7.48e-0522683int:UBE2A
InteractionRC3H2 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

7.49e-0566784int:RC3H2
InteractionSSRP1 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

8.30e-0568584int:SSRP1
InteractionGAPDH interactions

HNRNPDL RBM5 SYNCRIP HNRNPR

8.35e-0568684int:GAPDH
InteractionEED interactions

HNRNPDL RBM5 SS18 SYNCRIP HNRNPR

8.77e-05144585int:EED
InteractionTOP1 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

8.84e-0569684int:TOP1
InteractionSYNCRIP interactions

HNRNPDL SS18 SYNCRIP HNRNPR

1.01e-0472184int:SYNCRIP
InteractionLSM14A interactions

HNRNPDL SYNCRIP HNRNPR

1.13e-0426083int:LSM14A
InteractionSF3A2 interactions

RBM5 SYNCRIP HNRNPR

1.31e-0427383int:SF3A2
InteractionMETTL15 interactions

HNRNPDL SYNCRIP HNRNPR

1.32e-0427483int:METTL15
InteractionMTRES1 interactions

HNRNPDL SYNCRIP HNRNPR

1.55e-0428983int:MTRES1
InteractionDOT1L interactions

RBM5 SYNCRIP HNRNPR AKAP8

1.57e-0480784int:DOT1L
InteractionMTIF3 interactions

HNRNPDL SYNCRIP HNRNPR

1.68e-0429783int:MTIF3
InteractionMRRF interactions

HNRNPDL SYNCRIP HNRNPR

1.71e-0429983int:MRRF
InteractionGSPT1 interactions

HNRNPDL SYNCRIP HNRNPR

1.83e-0430683int:GSPT1
InteractionRNF125 interactions

SYNCRIP HNRNPR

1.88e-045382int:RNF125
InteractionHNRNPK interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

1.95e-0485384int:HNRNPK
InteractionZNF169 interactions

SYNCRIP HNRNPR

1.95e-045482int:ZNF169
InteractionCDC5L interactions

RBM5 SYNCRIP HNRNPR AKAP8

1.96e-0485584int:CDC5L
InteractionARIH2 interactions

HNRNPDL SYNCRIP HNRNPR

1.98e-0431483int:ARIH2
InteractionRBM42 interactions

HNRNPDL SYNCRIP HNRNPR

2.31e-0433183int:RBM42
InteractionCAND1 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

2.33e-0489484int:CAND1
InteractionILF3 interactions

HNRNPDL RBM5 SYNCRIP HNRNPR

2.35e-0489684int:ILF3
InteractionEWSR1 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

2.46e-0490684int:EWSR1
InteractionSF3A3 interactions

RBM5 SYNCRIP HNRNPR

2.50e-0434083int:SF3A3
InteractionPAIP2 interactions

SYNCRIP HNRNPR

2.66e-046382int:PAIP2
InteractionHNRNPA0 interactions

HNRNPDL SYNCRIP HNRNPR

2.70e-0434983int:HNRNPA0
InteractionMTERF3 interactions

HNRNPDL SYNCRIP HNRNPR

2.82e-0435483int:MTERF3
InteractionRALY interactions

HNRNPDL SYNCRIP HNRNPR

2.87e-0435683int:RALY
InteractionTNIP2 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

2.97e-0495284int:TNIP2
InteractionHNRNPDL interactions

HNRNPDL SYNCRIP HNRNPR

3.06e-0436483int:HNRNPDL
InteractionMIR138-1 interactions

SYNCRIP HNRNPR

3.10e-046882int:MIR138-1
InteractionPRC1 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

3.23e-0497384int:PRC1
InteractionHNRNPAB interactions

HNRNPDL SYNCRIP HNRNPR

3.24e-0437183int:HNRNPAB
InteractionMIR9-3 interactions

SYNCRIP HNRNPR

3.29e-047082int:MIR9-3
InteractionSNRNP70 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

3.38e-0498484int:SNRNP70
InteractionHECTD1 interactions

HNRNPDL SYNCRIP HNRNPR AKAP8

3.38e-0498484int:HECTD1
InteractionMIR29B2 interactions

SYNCRIP HNRNPR

3.38e-047182int:MIR29B2
InteractionMIR140 interactions

SYNCRIP HNRNPR

3.38e-047182int:MIR140
InteractionMIR122 interactions

SYNCRIP HNRNPR

3.38e-047182int:MIR122
InteractionDCAF4 interactions

HNRNPDL SYNCRIP AKAP8

3.42e-0437883int:DCAF4
InteractionMIR29B1 interactions

SYNCRIP HNRNPR

3.57e-047382int:MIR29B1
InteractionMIR18A interactions

SYNCRIP HNRNPR

3.57e-047382int:MIR18A
InteractionSMC5 interactions

HNRNPDL SS18 SYNCRIP HNRNPR

3.59e-04100084int:SMC5
InteractionMKRN2 interactions

HNRNPDL SYNCRIP HNRNPR

3.61e-0438583int:MKRN2
InteractionSNRPF interactions

HNRNPDL SYNCRIP HNRNPR

3.61e-0438583int:SNRPF
InteractionMIR20A interactions

SYNCRIP HNRNPR

3.67e-047482int:MIR20A
InteractionMIR15A interactions

SYNCRIP HNRNPR

3.77e-047582int:MIR15A
InteractionNEDD8 interactions

HNRNPDL SYNCRIP HNRNPR

3.83e-0439383int:NEDD8
InteractionMIR429 interactions

SYNCRIP HNRNPR

3.87e-047682int:MIR429
InteractionMIR16-1 interactions

SYNCRIP HNRNPR

3.87e-047682int:MIR16-1
InteractionMIR7-3 interactions

SYNCRIP HNRNPR

3.87e-047682int:MIR7-3
InteractionMIR199A2 interactions

SYNCRIP HNRNPR

3.87e-047682int:MIR199A2
InteractionMIR9-2 interactions

SYNCRIP HNRNPR

3.97e-047782int:MIR9-2
InteractionMIR200A interactions

SYNCRIP HNRNPR

3.97e-047782int:MIR200A
InteractionMRPL58 interactions

HNRNPDL SYNCRIP HNRNPR

4.04e-0440083int:MRPL58
InteractionMIR451A interactions

SYNCRIP HNRNPR

4.08e-047882int:MIR451A
InteractionMIR98 interactions

SYNCRIP HNRNPR

4.08e-047882int:MIR98
GeneFamilyRNA binding motif containing

HNRNPDL RBM5 SYNCRIP HNRNPR

6.38e-0721374725
CoexpressionGSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP

SS18 HNRNPR AKAP8

2.38e-0520083M3507
CoexpressionFISCHER_DREAM_TARGETS

HNRNPDL SS18 SYNCRIP HNRNPR

1.15e-0496984M149
CoexpressionIKEDA_MIR1_TARGETS_UP

SYNCRIP HNRNPR

1.16e-045482MM927
CoexpressionIKEDA_MIR1_TARGETS_UP

SYNCRIP HNRNPR

1.16e-045482M2372
CoexpressionLIU_COMMON_CANCER_GENES

HNRNPDL SYNCRIP

1.58e-046382M18694
CoexpressionBUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS

SYNCRIP HNRNPR

2.48e-047982M40003
CoexpressionSAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP

HNRNPDL HNRNPR

2.67e-048282M9224
CoexpressionGSE6259_33D1_POS_DC_VS_CD8_TCELL_UP

RBM5 HNRNPR

8.33e-0414582M6758
CoexpressionSCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP

HNRNPDL SYNCRIP

1.01e-0316082M1346
CoexpressionGSE14415_NATURAL_TREG_VS_TCONV_UP

HNRNPDL ZC3H6

1.01e-0316082M2976
CoexpressionGSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP

SS18 HNRNPR

1.04e-0316282M6673
CoexpressionSCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP

HNRNPDL SYNCRIP

1.09e-0316682MM563
CoexpressionPASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN

HNRNPDL SYNCRIP

1.17e-0317282M17811
CoexpressionPASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN

HNRNPDL SYNCRIP

1.18e-0317382MM580
CoexpressionGSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP

SS18 AKAP8

1.20e-0317482M8885
CoexpressionGRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN

HNRNPDL SYNCRIP AKAP8

1.29e-0377683M1107
CoexpressionXIE_TRASTUZUMAB_CARDIOTOXICITY_MMU_MIR_669C_3P_GENES

HAPLN3 AKAP8

1.32e-0318382MM17506
CoexpressionGRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN

HNRNPDL SYNCRIP AKAP8

1.38e-0379483MM982
CoexpressionGSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP

SYNCRIP AKAP8

1.48e-0319482M7288
CoexpressionGSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP

HAPLN3 AKAP8

1.51e-0319682M4928
CoexpressionGSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN

HNRNPDL AKAP8

1.51e-0319682M6111
CoexpressionGSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP

SYNCRIP AKAP8

1.53e-0319782M4237
CoexpressionGSE3982_MAC_VS_BASOPHIL_DN

RBM5 AKAP8

1.54e-0319882M5498
CoexpressionGSE17721_POLYIC_VS_CPG_8H_BMDC_DN

HNRNPDL SYNCRIP

1.56e-0319982M3947
CoexpressionGSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN

HNRNPDL HNRNPR

1.56e-0319982M3175
CoexpressionGSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN

HNRNPDL SS18

1.56e-0319982M4055
CoexpressionGSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP

RBM5 SS18

1.56e-0319982M5620
CoexpressionGSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN

SS18 SYNCRIP

1.57e-0320082M9490
CoexpressionGSE17721_CTRL_VS_POLYIC_1H_BMDC_UP

HNRNPDL AKAP8

1.57e-0320082M3707
CoexpressionGSE27786_CD4_TCELL_VS_NKCELL_UP

RBM5 AKAP8

1.57e-0320082M4822
CoexpressionGSE17721_CTRL_VS_CPG_2H_BMDC_UP

RBM5 AKAP8

1.57e-0320082M3759
CoexpressionGSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN

HNRNPDL AKAP8

1.57e-0320082M8331
CoexpressionGSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP

SS18 HNRNPR

1.57e-0320082M9942
CoexpressionGSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP

RBM5 SS18

1.57e-0320082M7789
CoexpressionGSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP

SYNCRIP AKAP8

1.57e-0320082M8868
CoexpressionGSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN

RBM5 HAPLN3

1.57e-0320082M7791
CoexpressionGSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN

SS18 SYNCRIP

1.57e-0320082M4041
CoexpressionGSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN

RBM5 AKAP8

1.57e-0320082M8278
CoexpressionGSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN

HNRNPDL HNRNPR

1.57e-0320082M3841
CoexpressionHALLMARK_MYC_TARGETS_V1

SYNCRIP HNRNPR

1.57e-0320082M5926
CoexpressionGSE42724_MEMORY_VS_B1_BCELL_UP

HNRNPDL AKAP8

1.57e-0320082M9794
CoexpressionHALLMARK_G2M_CHECKPOINT

SS18 SYNCRIP

1.57e-0320082M5901
CoexpressionGSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN

SYNCRIP HNRNPR

1.57e-0320082M9628
CoexpressionBIDUS_METASTASIS_UP

HNRNPDL HNRNPR

1.92e-0322182M15866
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274

HNRNPDL ZC3H6 SYNCRIP

9.27e-0525683gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

RBM5 SYNCRIP HNRNPR

7.26e-071078360b272f5c89bea8a2714f870e18b7ac89a4a4bf6
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P3|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

RBM5 SYNCRIP HNRNPR

7.26e-0710783c41bc8810df67158f0ae9f6015c965a8ebd96965
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

RBM5 SYNCRIP HNRNPR

2.13e-061538388ca2d2c2ab19fbee13e18951b993ee05dd30f67
ToppCellGlobus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32

RBM5 SYNCRIP HNRNPR

2.13e-0615383553dff9688a1996d8f4ba16e60c683593d781389
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4|Hippocampus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

2.51e-04136820185486c39700dd2f72d79be6d283494dd8379c9
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2|Hippocampus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

2.51e-04136823e13dc0634f3b05e9f9e6c3193f843f62e603b78
ToppCellHippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

4.39e-041808244988c34861df359a68376500c42a64fbcc4b431
ToppCellHippocampus-Macroglia-POLYDENDROCYTE|Hippocampus / BrainAtlas - Mouse McCarroll V32

SYNCRIP HNRNPR

4.78e-04188828bd6f2cd1aadbd6f9ed31b160f59c1eff144e1dc
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.25e-04197827290f05d0b8465637420119941bcbf2fae44a7e4
ToppCell10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.25e-0419782106b0f9a0425facc634feb7498c9ba2c55edfbf8
ToppCell10x5'v1-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.25e-041978231dfd9842410b5c629f39b5130233995dceb0aef
ToppCell10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.36e-0419982cdee798e3586e4e7a15de598239090a85752ea1e
ToppCell10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.36e-0419982713dfd8552635645db5e0b5721c64e5c9b4aa06c
ToppCell10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.36e-0419982ea75804c34989c99aab542e6d72617ed144819b6
ToppCellmegakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class

HNRNPDL HNRNPR

5.36e-041998299a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.36e-04199825478b78349b5d8d57f30bb650dcbd5fdb84283d6
ToppCellLPS_only|World / Treatment groups by lineage, cell group, cell type

HNRNPDL HAPLN3

5.36e-0419982852cf595c2255983cff9045f2bb746d4391cf5ba
ToppCell10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.36e-0419982fe3b7d540a644dfc6beea171c809b4d1ba4e188f
ToppCellMegakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass

SYNCRIP HNRNPR

5.36e-04199826f159c1215439ec22374903124085746fa8da333
ToppCell10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.36e-04199828daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCell10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.41e-04200820fd9a8730b7dc461ddf4586899d363541e72d8ba
ToppCell10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.41e-0420082364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93
ToppCell10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.41e-042008219a4213f180ac2d29625d140b602a93a74ab3fdd
ToppCell10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

HNRNPDL HNRNPR

5.41e-0420082c28d4ca51d2e2a3a22784ee251975f16a55b0297
ComputationalRNA splicing.

HNRNPDL RBM5 HNRNPR

4.17e-066563MODULE_183
ComputationalNeighborhood of DENR

SYNCRIP HNRNPR

3.27e-045162GNF2_DENR
ComputationalNeighborhood of SMC1L1

SYNCRIP HNRNPR

4.84e-046262MORF_SMC1L1
ComputationalNeighborhood of DDX5

HNRNPDL RBM5

5.00e-046362GNF2_DDX5
ComputationalNeighborhood of KPNB1

SYNCRIP HNRNPR

6.70e-047362GNF2_KPNB1
ComputationalNeighborhood of APEX1

SYNCRIP HNRNPR

1.06e-039262GNF2_APEX1
ComputationalNeighborhood of HDAC1

HNRNPDL HNRNPR

1.52e-0311062GNF2_HDAC1
ComputationalNeighborhood of FBL

SYNCRIP HNRNPR

2.65e-0314662GNF2_FBL
ComputationalNeighborhood of MYST2

SYNCRIP HNRNPR

3.66e-0317262GCM_MYST2
Drugbromovanin

HNRNPDL SYNCRIP HNRNPR

9.30e-0612783ctd:C515564
DrugHarmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A

HNRNPDL SS18 SYNCRIP

2.78e-05183832750_DN
DrugDilazep dihydrochloride [20153-98-4]; Down 200; 6uM; MCF7; HT_HG-U133A

HNRNPDL RBM5 SYNCRIP

2.87e-05185834688_DN
DrugAcacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A

HNRNPDL RBM5 SYNCRIP

3.20e-05192836044_DN
Drug0175029-0000 [211245-78-2]; Down 200; 1uM; PC3; HT_HG-U133A

HNRNPDL SS18 SYNCRIP

3.46e-05197833694_DN
Drug3-chlorobenzylamine

SS18 SYNCRIP

4.36e-049182CID000077802
Drugpoly(G

HNRNPDL RBM5

6.82e-0411482CID000439502
DrugAC1OCADI

SYNCRIP HNRNPR

8.86e-0413082CID006914639
DrugAC1L1AUZ

SYNCRIP HNRNPR

1.29e-0315782CID000001160
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

SYNCRIP AKAP8

1.39e-03163825594_DN
DrugSAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA

SYNCRIP AKAP8

1.52e-03171821000_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA

SYNCRIP AKAP8

1.54e-03172821072_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

RBM5 AKAP8

1.54e-03172824344_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

RBM5 AKAP8

1.54e-03172824112_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

SS18 AKAP8

1.56e-03173824237_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

SYNCRIP AKAP8

1.58e-03174826579_DN
DrugAC1NRA5C

SYNCRIP HNRNPR

1.58e-0317482CID005287709
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

SYNCRIP AKAP8

1.58e-03174823462_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

RBM5 AKAP8

1.58e-03174825693_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

SS18 AKAP8

1.58e-03174825065_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

RBM5 AKAP8

1.61e-03176824632_DN
Drugresveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA

HNRNPDL SYNCRIP

1.61e-0317682958_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

SS18 AKAP8

1.61e-03176827499_DN
Drugtrichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA

SYNCRIP AKAP8

1.61e-0317682981_DN
Drugtrichostatin A ; Down 200; 1uM; MCF7; HT_HG-U133A_EA

SYNCRIP AKAP8

1.63e-0317782873_DN
DrugPhenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A

SS18 SYNCRIP

1.63e-03177824652_DN
Drugresveratrol; Down 200; 10uM; MCF7; HT_HG-U133A_EA

HNRNPDL SYNCRIP

1.63e-0317782841_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

RBM5 AKAP8

1.63e-03177826340_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

SS18 AKAP8

1.65e-03178824184_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA

RBM5 AKAP8

1.65e-03178821112_DN
Drugfisetin; Down 200; 50uM; PC3; HG-U133A

HNRNPDL RBM5

1.65e-0317882579_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A

SYNCRIP AKAP8

1.67e-03179821175_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

RBM5 AKAP8

1.67e-03179826910_DN
Drugtrichostatin A; Down 200; 0.1uM; MCF7; HG-U133A

RBM5 AKAP8

1.67e-0317982332_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

RBM5 AKAP8

1.67e-03179825484_DN
DrugSAHA; Down 200; 10uM; HL60; HT_HG-U133A

SYNCRIP AKAP8

1.69e-03180822680_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

RBM5 AKAP8

1.69e-03180824821_DN
DrugEtoposide [33419-42-0]; Down 200; 6.8uM; HL60; HG-U133A

HNRNPDL SYNCRIP

1.69e-03180821626_DN
DrugH-7 dihydrochloride; Down 200; 100uM; MCF7; HT_HG-U133A

HNRNPDL RBM5

1.71e-03181825963_DN
DrugChrysin [480-40-0]; Down 200; 15.8uM; HL60; HT_HG-U133A

HNRNPDL SYNCRIP

1.71e-03181823106_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HG-U133A

RBM5 AKAP8

1.72e-03182821891_DN
Drugtrichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A

RBM5 AKAP8

1.76e-03184826916_DN
DrugApigenin [520-36-5]; Down 200; 14.8uM; HL60; HT_HG-U133A

HNRNPDL SYNCRIP

1.76e-03184821321_DN
DrugAmoxicillin [26787-78-0]; Down 200; 11uM; MCF7; HT_HG-U133A

HNRNPDL SS18

1.78e-03185822620_DN
DrugHarmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A

HNRNPDL SYNCRIP

1.78e-03185827209_DN
Drug0175029-0000 [211245-78-2]; Down 200; 10uM; PC3; HT_HG-U133A

HNRNPDL RBM5

1.80e-03186826875_DN
DrugTrichostatin A, Streptomyces sp.; Down 200; 1uM; HL60; HT_HG-U133A

SYNCRIP AKAP8

1.80e-03186822694_DN
DrugSulfaphenazole [526-08-9]; Up 200; 12.8uM; PC3; HT_HG-U133A

HNRNPDL SS18

1.82e-03187821794_UP
DrugCantharidin [56-25-7]; Down 200; 20.4uM; HL60; HT_HG-U133A

HNRNPDL RBM5

1.82e-03187823075_DN
DrugPicrotoxinin [17617-45-7]; Down 200; 13.6uM; HL60; HT_HG-U133A

RBM5 SS18

1.84e-03188822161_DN
DrugIsoflupredone acetate [338-98-7]; Up 200; 9.6uM; PC3; HT_HG-U133A

HNRNPDL SS18

1.84e-03188821832_UP
DrugLY 294002; Down 200; 10uM; HL60; HT_HG-U133A

HNRNPDL SYNCRIP

1.84e-03188821177_DN
Drugresveratrol; Down 200; 50uM; MCF7; HG-U133A

HNRNPDL AKAP8

1.84e-0318882595_DN
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA

HNRNPDL SYNCRIP

1.86e-03189821065_DN
DrugApigenin [520-36-5]; Down 200; 14.8uM; MCF7; HT_HG-U133A

HNRNPDL SYNCRIP

1.86e-03189824401_DN
DrugCloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A

RBM5 SS18

1.86e-03189824271_DN
Drug0175029-0000 [211245-78-2]; Down 200; 1uM; PC3; HT_HG-U133A

HNRNPDL SYNCRIP

1.86e-03189827392_DN
Drug0173570-0000 [211245-44-2]; Down 200; 10uM; PC3; HT_HG-U133A

HNRNPDL SS18

1.86e-03189823690_DN
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA

HNRNPDL SYNCRIP

1.88e-03190821077_DN
DrugLuteolin [491-70-3]; Down 200; 14uM; MCF7; HT_HG-U133A

HNRNPDL SYNCRIP

1.88e-03190823379_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A

RBM5 SS18

1.88e-03190826709_DN
DrugEstradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A

RBM5 SS18

1.88e-03190826718_DN
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA

HNRNPDL SYNCRIP

1.88e-03190821074_DN
DrugAzacytidine-5 [320-67-2]; Down 200; 16.4uM; PC3; HT_HG-U133A

RBM5 SS18

1.88e-03190824010_DN
DrugN6-methyladenosine [1867-73-8]; Down 200; 14.2uM; HL60; HT_HG-U133A

HNRNPDL SS18

1.92e-03192821271_DN
DrugSpironolactone [52-01-7]; Down 200; 9.6uM; HL60; HG-U133A

HNRNPDL HNRNPR

1.94e-03193821380_DN
DrugEtifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A

RBM5 SS18

1.94e-03193822477_DN
DrugChrysin [480-40-0]; Down 200; 15.8uM; MCF7; HT_HG-U133A

HNRNPDL SYNCRIP

1.94e-03193826485_DN
DrugZaprinast [37762-06-4]; Down 200; 14.8uM; PC3; HT_HG-U133A

RBM5 SS18

1.94e-03193826749_DN
DrugPyrantel tartrate [33401-94-4]; Down 200; 11.2uM; PC3; HT_HG-U133A

RBM5 SS18

1.94e-03193825088_DN
DrugAG-028671 [847803-03-6]; Up 200; 10uM; MCF7; HT_HG-U133A

RBM5 SS18

1.94e-03193826587_UP
Drugtrichostatin A; Down 200; 0.1uM; ssMCF7; HG-U133A

RBM5 AKAP8

1.94e-0319382413_DN
DrugSC 19220; Up 200; 10uM; PC3; HT_HG-U133A

RBM5 SS18

1.96e-03194827065_UP
DrugSalsolinol hydrobromide [38221-21-5]; Down 200; 15.4uM; PC3; HT_HG-U133A

RBM5 SS18

1.96e-03194824232_DN
Drug2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A

RBM5 HNRNPR

1.96e-0319482433_DN
DrugF0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A

RBM5 SS18

1.96e-03194826424_UP
DrugGriseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A

HNRNPDL SS18

1.96e-03194822293_DN
Drugphenanthridinone; Down 200; 51.2uM; MCF7; HT_HG-U133A_EA

HNRNPDL SYNCRIP

1.96e-03194821115_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A

RBM5 SS18

1.96e-03194825017_DN
DrugDichlorphenamide [120-97-8]; Down 200; 13.2uM; MCF7; HT_HG-U133A

RBM5 SS18

1.96e-03194823366_DN
DrugProcainamide hydrochloride [614-39-1]; Down 200; 14.8uM; PC3; HT_HG-U133A

RBM5 SS18

1.96e-03194824602_DN
DrugLY 294002; Down 200; 10uM; MCF7; HT_HG-U133A

HNRNPDL SYNCRIP

1.96e-03194826995_DN
DrugAcacetin [480-44-4]; Down 200; 14uM; MCF7; HT_HG-U133A

HNRNPDL SYNCRIP

1.98e-03195823942_DN
Drug0393-0188; Up 200; 10uM; MCF7; HT_HG-U133A

RBM5 SS18

1.98e-03195827531_UP
DrugCefoperazone dihydrate; Down 200; 5.8uM; MCF7; HT_HG-U133A

RBM5 SS18

1.98e-03195825424_DN
DrugFursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; HL60; HT_HG-U133A

RBM5 SS18

1.98e-03195822929_DN
DrugTrichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A

HNRNPDL SYNCRIP

1.98e-03195821561_DN
DrugDipyridamole [58-32-2]; Down 200; 8uM; PC3; HG-U133A

HNRNPR AKAP8

1.98e-03195821934_DN
DrugPNU-0251126 [267429-19-6]; Down 200; 10uM; MCF7; HT_HG-U133A

HNRNPDL RBM5

2.00e-03196824711_DN
DrugDebrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A

RBM5 AKAP8

2.00e-03196825288_UP
DrugMevalonic-D, L acid lactone [674-26-0]; Down 200; 30.8uM; HL60; HT_HG-U133A

RBM5 SS18

2.00e-03196822718_DN
DrugPaclitaxel [33069-62-4]; Down 200; 4.6uM; HL60; HG-U133A

HNRNPDL HNRNPR

2.00e-03196822043_DN
DrugChlorpromazine hydrochloride [69-09-0]; Down 200; 11.2uM; HL60; HT_HG-U133A

RBM5 SS18

2.00e-03196821864_DN
DrugFolic acid [59-30-3]; Down 200; 9uM; HL60; HG-U133A

HNRNPR AKAP8

2.00e-03196821790_DN
DrugPNU-0293363 [326823-19-2]; Down 200; 10uM; PC3; HT_HG-U133A

HNRNPDL SS18

2.00e-03196826563_DN
Drug9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A

RBM5 SS18

2.00e-03196827552_UP
Drugradicicol; Up 200; 0.1uM; SKMEL5; HG-U133A

SS18 HNRNPR

2.00e-0319682493_UP
DrugEdrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HG-U133A

HNRNPDL RBM5

2.00e-03196821936_DN
DrugEthambutol dihydrochloride [1070-11-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A

RBM5 SS18

2.00e-03196824120_DN
DrugFluvastatin sodium salt [93957-55-2]; Down 200; 9.2uM; MCF7; HT_HG-U133A

SS18 AKAP8

2.00e-03196825290_DN

Protein segments in the cluster

PeptideGeneStartEntry
GYENYNYYGAQNTSV

AKAP8

31

O43823
WNQGFNNYYDQGYGN

HNRNPDL

346

O14979
NNYYDQGYGNYNSAY

HNRNPDL

351

O14979
YNGFYYSNSANDQNL

HAPLN3

21

Q96S86
SGNYGYKSENQEFYQ

SYNCRIP

601

O60506
SGNYGYNNDNQEFYQ

HNRNPR

611

O43390
YNNDNQEFYQDTYGQ

HNRNPR

616

O43390
DGYAQYAQYSQDYQQ

RBM5

366

P52756
DNFGNYSDDNFGNYG

ZC3H6

146

P61129
YYEGGNSQYGQQQDA

SS18

321

Q15532